Advertisement

Topics

Regeneron Pharmaceuticals Company Profile

09:38 EDT 25th September 2017 | BioPortfolio

Regeneron is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates in clinical trials for the potential treatment of obesity, rheumatoid arthritis, and cancer. The Company also has preclinical programs in asthma, allergies, and other diseases and disorders. Regeneron has developed several proprietary platform technologies, which it has incorporated into a comprehensive discovery and development process designed to understand thoroughly the biology of specific disease states, discover potential therapeutic candidates, and evaluate these candidates in clinical trials.

Location

777 Old Saw Mill River Road
Tarrytown
NY
10591-6707
United States of America

Contact

Phone: 914 347 7000
Fax: 914 347 2847


News Articles [1517 Associated News Articles listed on BioPortfolio]

Regeneron Pharmaceuticals Profit Rises 48% In Q2

WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals (REGN) revealed earnings for its second quarter that rose compared to the same period last year.The company said its bottom line climbed to $487 mi...

Regeneron and Inovio enter trial collaboration for glioblastoma therapy

Regeneron Pharmaceuticals Inc. and Inovio Pharmaceuticals Inc. entered into a trial collaboration to study a combination of their therapies (Regeneron’s REGN2810 with Inovio’s INO5401 and INO9012)...

Regeneron and Inovio Enter Agreement for Glioblastoma Combination Therapy

TARRYTOWN, N.Y. and PLYMOUTH MEETING, Pa., May 8, 2017 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced a clinical stu...

Regeneron abandons RSV drug after Phase III flop

US biotech firm Regeneron Pharmaceuticals saw its share price fall 2.5% in pre-market trading, after…

Eylea boosts Regeneron’s performance above expectations

US biotech firm Regeneron Pharmaceuticals (Nasdaq: REGN) today announced financial results for the second…

Regeneron Pharmaceuticals (REGN) Receiving Somewhat Favorable News Coverage, Analysis Shows

Headlines about Regeneron Pharmaceuticals have trended somewhat positive on Saturday, according to Accern Sentiment. The research firm identifies positive and negative media coverage by monitoring mor...

Analysts' Weekly Ratings Changes for Regeneron Pharmaceuticals

They now have a "hold" rating on the stock. 5/15/2017 - Regeneron Pharmaceuticals had its "hold" rating reaffirmed by analysts at Cowen and Company.

Regeneron Announces Presentation at the Deutsche Bank 2012 dbAccess BioFEST

TARRYTOWN, N.Y., Nov. 27, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast its presentation at the Deutsche Bank 2012 dbAccess BioFEST on Monday, December 3, 2012....

Drugs and Medications [272 Associated Drugs and Medications listed on BioPortfolio]

Eylea [Regeneron Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use EYLEA safely and effectively. See full prescribing information for EYLEA. EYLEA (aflibercept) Injection For Intravitreal Injection Ini...

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Arcalyst [Regeneron Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use ARCALYST safely and effectively. See full prescribing information for ARCALYST. ARCALYST (rilonacept)Injection for Subcutaneous UseIni...

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

PubMed Articles [160 Associated PubMed Articles listed on BioPortfolio]

Safety and Efficacy of Ziv-Aflibercept in the Treatment of Refractory Diabetic Macular Edema.

To evaluate the safety and efficacy of ziv-aflibercept (Zaltrap; Sanofi-Aventis, Bridgewater, NJ/Regeneron Pharmaceuticals, Tarrytown, NY) in the treatment of refractory diabetic macular edema (DME).

Announcing the 2017 Pharmaceuticals Travel Award for Young Post-Doctoral Researchers.

Last year, for the first time in its history, our Journal was able to offer a travel grant of 800 CHF to a young researcher in the field of medicinal chemistry.

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Chiral pharmaceuticals: A review on their environmental occurrence and fate processes.

More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the same pharmaceutical have identical physicochemical properties, but may exhibit differences in pharmacokinetics,...

Comparative study on pharmaceuticals adsorption in reclaimed water desalination concentrate using biochar: Impact of salts and organic matter.

The synergistic impact of salts and organic matter on adsorption of ibuprofen and sulfamethoxazole by three types of biochar and an activated carbon was investigated using reclaimed water reverse osmo...

Clinical Trials [201 Associated Clinical Trials listed on BioPortfolio]

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects Under Fasting Condition

- Objective: - To compare the rate and extent of absorption of Citalopram Hydrobromide Tablets 40 mg: Test Product: Citalopram Hydrobromide Tablets 40 mg manufactured b...

Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions

To compare the single-dose oral bioavailability of hydrochlorothiazide 50 mg tablet of Ohm Laboratories (A subsidiary of Ranbaxy pharmaceuticals USA) with hydrochlorothiazide 50 mg tablet ...

Companies [1283 Associated Companies listed on BioPortfolio]

Regeneron Pharmaceuticals, Inc.

Regeneron is a fully integrated biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions. In addition to ARCALYST® (rilonacept...

Regeneron Pharmaceuticals

Regeneron is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candida...

Regeneron

Regeneron has several product candidates progressing through all stages of human clinical trials, for the potential treatment of a diverse set of diseases, including cancer, eye diseases, and inflamma...

ARTEMIS Pharmaceuticals

ARTEMIS Pharmaceuticals, based in Cologne Germany was founded in 1998 and has made significant advances to provide rapid, efficient and sophisticated techniques for the analysis of gene function in ve...

Psychiatric Genomics, Inc.

Dr. C. Anthony Altar is President and Chief Scientific Officer at Psychiatric Genomics. His research team is responsible for gene discovery, medicinal chemistry, and drug discovery efforts. Dr. Altar ...

More Information about "Regeneron Pharmaceuticals" on BioPortfolio

We have published hundreds of Regeneron Pharmaceuticals news stories on BioPortfolio along with dozens of Regeneron Pharmaceuticals Clinical Trials and PubMed Articles about Regeneron Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Regeneron Pharmaceuticals Companies in our database. You can also find out about relevant Regeneron Pharmaceuticals Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Obesity
Obesity is the condition in which excess fat has accumulated in the body (mostly in subcutaneous tissues). clinical obesity is considered to be present when a person has a BMI of over 30 (Oxford Dictionary of Medicine). It is becoming increasing common i...

Orthopedics
Arthroplasty Joint Disorders Orthopedics Spinal Cord Disorders Orthopedics is the science or practice of correcting deformities caused by disease or damage to the bones and joints of the skeleton. This specialized branch of surgery may ...


Corporate Database Quicklinks



Searches Linking to this Company Record